C3f fragment, Human c3 (1286-1297) represents a short sequence released during C3 activation. The peptide contains residues that contribute to complement regulation and interaction with downstream components. Its defined length suits NMR and biophysical characterization. Researchers use it to investigate proteolytic processing, structural transitions, and peptide-protein recognition events.
CAT No: C01008
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More